EX-1.1
from 8-K
50 pages
703,731 Common Stock Units, 9,815,900 Pfw Units, 703,731 Shares of Common Stock, Pre-Funded Warrants Exercisable Into 9,815,900 Shares of Common Stock, Series J Warrants Exercisable Into 10,519,631 Shares of Common Stock, Series K Warrants Exercisable Into 10,519,631 Shares of Common Stock, Series L Warrants Exercisable Into 10,519,631 Shares of Common Stock, of Calidi Biotherapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 10-Q
47 pages
1,472,764 Shares of Common Stock, Pre-Funded Warrants Exercisable Into 1,528,000 Shares of Common Stock and Warrants Exercisable Into 3,000,764 Shares of Common Stock of Calidi Biotherapeutics, Inc. Underwriting Agreement
12/34/56